We are live on ! Find out more
FAF

Fjarde Ap-fonden Portfolio holdings

AUM $20.9B
1-Year Est. Return 36.93%
This Fund
S&P 500
This Quarter Est. Return
+6.53%
1 Year Est. Return
+36.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.19B
AUM Growth
-$76.9M
Cap. Flow
-$312M
Cap. Flow %
-7.45%
Top 10 Hldgs %
17.53%
Holding
630
New
4
Increased
15
Reduced
603
Closed
5

Top Buys

Rank Stock Value
1
FTI icon
TechnipFMC
FTI
+$4.17M
2
AMD icon
Advanced Micro Devices
AMD
+$1.68M
3
DBRG icon
DigitalBridge
DBRG
+$1.6M
4
ABT icon
Abbott
ABT
+$1.26M
5
PE
PARSLEY ENERGY INC
PE
+$649K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$11.2M
2
MSFT icon
Microsoft
MSFT
+$6.78M
3
JPM icon
JPMorgan Chase
JPM
+$5.2M
4
XOM icon
ExxonMobil
XOM
+$5.06M
5
SE
Spectra Energy Corp Wi
SE
+$5M

Sector Composition

Rank Sector Weight
1 Technology 16.31%
2 Financials 16.2%
3 Healthcare 14.66%
4 Communication Services 10.53%
5 Consumer Discretionary 9.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
V icon
26
Visa
V
$701B
$33.3M 0.8%
374,987
-30,036
-7% -$2.58M
IBM icon
27
IBM
IBM
$213B
$32.1M 0.77%
192,891
-14,472
-7% -$2.43M
UNH icon
28
UnitedHealth
UNH
$382B
$31.4M 0.75%
191,482
-13,495
-7% -$2.21M
PEP icon
29
PepsiCo
PEP
$196B
$30.5M 0.73%
272,591
-14,078
-5% -$1.51M
ORCL icon
30
Oracle
ORCL
$339B
$27.9M 0.67%
624,772
-46,442
-7% -$1.93M
BRK.B icon
31
Berkshire Hathaway Class B
BRK.B
$1.1T
$27.5M 0.66%
165,059
-13,395
-8% -$2.24M
AMGN icon
32
Amgen
AMGN
$209B
$24.5M 0.58%
149,108
-11,320
-7% -$1.88M
MMM icon
33
3M
MMM
$91.8B
$23.3M 0.56%
145,813
-10,777
-7% -$1.65M
MDT icon
34
Medtronic
MDT
$112B
$22.7M 0.54%
282,285
-19,671
-7% -$1.54M
SLB icon
35
SLB Ltd
SLB
$72.7B
$22.7M 0.54%
290,088
-19,821
-6% -$1.62M
MA icon
36
Mastercard
MA
$498B
$21.8M 0.52%
194,157
-14,983
-7% -$1.64M
MCD icon
37
McDonald's
MCD
$193B
$21.7M 0.52%
167,374
-16,135
-9% -$2.02M
BA icon
38
Boeing
BA
$169B
$20.9M 0.5%
118,366
-9,628
-8% -$1.64M
ABBV icon
39
AbbVie
ABBV
$465B
$20.8M 0.5%
319,533
-23,608
-7% -$1.48M
CELG
40
DELISTED
Celgene Corp
CELG
$19.3M 0.46%
155,171
-11,094
-7% -$1.33M
AGN
41
DELISTED
Allergan plc
AGN
$18.5M 0.44%
77,266
-9,099
-11% -$2.12M
BMY icon
42
Bristol-Myers Squibb
BMY
$129B
$18.2M 0.43%
334,779
-23,954
-7% -$1.31M
USB icon
43
US Bancorp
USB
$97.9B
$18.1M 0.43%
351,451
-26,749
-7% -$1.43M
HON icon
44
Honeywell
HON
$76.4B
$18M 0.43%
159,973
-10,845
-6% -$1.2M
RTX icon
45
RTX Corp
RTX
$290B
$18M 0.43%
254,845
-20,181
-7% -$1.42M
GILD icon
46
Gilead Sciences
GILD
$165B
$17.9M 0.43%
263,790
-18,769
-7% -$1.32M
AVGO icon
47
Broadcom
AVGO
$1.76T
$17.9M 0.43%
817,920
-42,870
-5% -$883K
BKNG icon
48
Booking.com
BKNG
$156B
$17.6M 0.42%
246,850
-16,900
-6% -$1.12M
SBUX icon
49
Starbucks
SBUX
$119B
$17.2M 0.41%
294,166
-23,133
-7% -$1.31M
QCOM icon
50
Qualcomm
QCOM
$164B
$17.1M 0.41%
297,925
-19,969
-6% -$1.16M

Similar funds

Fjarde Ap-fonden's Q1 2017 Portfolio in Review

As of Q1 2017, Fjarde Ap-fonden held 630 positions worth $4.19B, down 1.8% from $4.26B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Fjarde Ap-fonden withdrew a net $312M in Q1 2017, closing 5 positions and reducing 603 holdings. Its most notable exit was Spectra Energy Corp Wi, an estimated $5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Fjarde Ap-fonden opened a new position in TechnipFMC worth $4.08M.

  • Fjarde Ap-fonden's largest Q1 2017 buy was TechnipFMC: 168,810 shares worth $4.08M.
  • Fjarde Ap-fonden added most to Abbott in Q1 2017, an estimated $1.26M increase.
  • Fjarde Ap-fonden's biggest Q1 2017 reduction was Apple, cutting an estimated $11.2M.
  • Fjarde Ap-fonden fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $5M.
  • Fjarde Ap-fonden's ten largest holdings make up 18% of its $4.19B portfolio in Q1 2017.
  • Fjarde Ap-fonden opened 4 new positions and closed 5 in Q1 2017.
  • Fjarde Ap-fonden's portfolio value fell 1.8% quarter-over-quarter to $4.19B.

Based on Fjarde Ap-fonden's 13F filing for Q1 2017, filed 10 May 2017.